McGarvey, Lorcan
Sher, Mandel
Shvarts, Yury Grigorievich
Lu, Susan
Wu, Wen-Chi
Xu, Ping
Schelfhout, Jonathan
La Rosa, Carmen
Nguyen, Allison Martin
Reyfman, Paul A.
Afzal, Amna Sadaf
Article History
Received: 2 December 2022
Accepted: 4 February 2023
First Online: 6 March 2023
Declarations
:
: LPM has received grants and personal fees from Merck Sharp & Dohme; personal fees from Applied Clinical Intelligence; grants from Asthma UK, Northern Ireland Chest Heart and Stroke, NC3Rs, British Heart Foundation, and Chiesi; travel and subsistence for attendance at scientific meetings from Boehringer Ingelheim, GlaxoSmithKline, and Chiesi; and advisory board or consultancy fees from Almirall, NAPP, GlaxoSmithKline, and Boehringer Ingelheim. MRS has received grants and personal fees from Merck & Co., Inc; is a consultant to Bayer, Bellus, and NeRRe Therapeutics; and has done clinical research with Bellus. YGS reports no conflicts. SL, WCW, PX, JS, CL, AMN, PAR, and ASA are current or former employees of Merck & Co., Inc., Rahway, NJ, USA.